Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(17):1297; doi:10.1093/jnci/93.17.1297
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Stefanek, M.
Right arrow Articles by Nelson, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stefanek, M.
Right arrow Articles by Nelson, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 17, 1297, September 5, 2001
© 2001 Oxford University Press

REVIEW

Risk-Reduction Mastectomy: Clinical Issues and Research Needs

Michael Stefanek, Lynn Hartmann, Wendy Nelson

Affiliations of authors: M. Stefanek, W. Nelson, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; L. Hartmann, Division of Medical Oncology, Mayo Clinic, Rochester, MN.

Correspondence to: Michael Stefanek, Ph.D., National Institutes of Health, 6130 Executive Blvd., EPN 4066, Bethesda, MD 20892 (e-mail: ms496r{at}nih.gov).

Risk-reduction mastectomy (RRM), also known as bilateral prophylactic mastectomy, is a controversial clinical option for women who are at increased risk of breast cancer. High-risk women, including women with a strong family history of breast cancer and BRCA1/2 mutation carriers, have several clinical options: risk-reduction surgery (bilateral mastectomy and bilateral oophorectomy), surveillance (mammography, clinical breast examination, and breast self-examination), and chemoprevention (tamoxifen). We review research in a number of areas central to our understanding of RRM, including recent data on 1) the effectiveness of RRM in reducing breast cancer risk, 2) the perception of RRM among women at increased risk and health-care providers, 3) the decision-making process for follow-up care of women at high risk, and 4) satisfaction and psychological status after surgery. We suggest areas of future research to better guide high-risk women and their health-care providers in the decision-making process.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The OncologistHome page
F. M. Muggia
The Emerging Roles of Screening and Prevention in Women's Cancer
Oncologist, April 1, 2004; 9(2): 228 - 231.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. Wideroff, A. N. Freedman, L. Olson, C. N. Klabunde, W. Davis, K. P. Srinath, R. T. Croyle, and R. Ballard-Barbash
Physician Use of Genetic Testing for Cancer Susceptibility: Results of a National Survey
Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 295 - 303.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
V. R. Grann, J. S. Jacobson, D. Thomason, D. Hershman, D. F. Heitjan, and A. I. Neugut
Effect of Prevention Strategies on Survival and Quality-Adjusted Survival of Women With BRCA1/2 Mutations: An Updated Decision Analysis
J. Clin. Oncol., May 15, 2002; 20(10): 2520 - 2529.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
D. G. Evans, A. Howell, A. Baildam, A. Brain, F. Lalloo, and P. Hopwood
Re: Risk-Reduction Mastectomy: Clinical Issues and Research Needs
J Natl Cancer Inst, February 20, 2002; 94(4): 307 - 307.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Stefanek, L. Hartmann, and W. Nelson
RESPONSE: Re: Risk-Reduction Mastectomy: Clinical Issues and Research Needs
J Natl Cancer Inst, February 20, 2002; 94(4): 307 - 308.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
G. P. Swanson
Re: Risk-Reduction Mastectomy: Clinical Issues and Research Needs
J Natl Cancer Inst, January 16, 2002; 94(2): 143 - 143.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Stefanek, L. Hartmann, and W. Nelson
RESPONSE: Re: Risk-Reduction Mastectomy: Clinical Issues and Research Needs
J Natl Cancer Inst, January 16, 2002; 94(2): 143 - 144.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.